Cover Image
市场调查报告书

梅毒:全球临床实验趋势

Syphilis Global Clinical Trials Review, H2, 2016

出版商 GlobalData 商品编码 175085
出版日期 内容信息 英文 42 Pages
订单完成后即时交付
价格
Back to Top
梅毒:全球临床实验趋势 Syphilis Global Clinical Trials Review, H2, 2016
出版日期: 2016年12月14日 内容信息: 英文 42 Pages
简介

本报告提供梅毒相关临床研究之最新趋势分析,提供您疾病·治疗方法概要,及G7、E7各国的临床实验状况,各地区·各期·各阶段的进展,并汇整有潜力的赞助商,各企业及研究机关的研究进行状况,有潜力的药剂比较等信息。

本报告概要

各地区的临床实验情形

  • 各国临床实验数量和平均实验人数
    • 主要国家的临床实验数量:亚太地区
    • 主要国家的临床实验数量:欧洲
    • 主要国家的临床实验数量:北美
    • 主要国家的临床实验数量:中东/非洲地区

G7各国的临床实验数量:梅毒临床实验数量占感染疾病临床实验数量比率

各阶段 (期) 临床实验数量:G7各国

G7各国的临床实验数量:各阶段 (期)

E7各国的临床实验数量:梅毒临床实验数量占感染疾病临床实验数量比率

E7各国的临床实验数量:各阶段 (期)

各阶段 (期) 临床实验数量

各进展状况临床实验数量

各评估项目临床实验数量

一定期间所采用的受验人数

赞助商类别的临床实验数量

有潜力的赞助商

临床实验主要参加企业 - 梅毒治疗药

有潜力的药剂

临床实验简介的基本数据

附录

图表

本网页内容可能与最新版本有所差异。详细情况请与我们联系。

目录
Product Code: GDHC3989CTIDB

GlobalData's clinical trial report, "Syphilis Global Clinical Trials Review, H2, 2016" provides an overview of Syphilis clinical trials scenario. This report provides top line data relating to the clinical trials on Syphilis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Middle East and Africa
  • Clinical Trials by G7 Countries: Proportion of Syphilis to Infectious Disease Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Syphilis to Infectious Disease Clinical Trials
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Syphilis Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profile Snapshots
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
  • Source

List of Tables

  • Syphilis Therapeutics, Global, Clinical Trials by Region, 2016*
  • Syphilis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016*
  • Syphilis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016*
  • Syphilis Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2016*
  • Syphilis Therapeutics Clinical Trials, Europe, Top Countries, 2016*
  • Syphilis Therapeutics Clinical Trials, North America, Top Countries, 2016*
  • Syphilis Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2016*
  • Proportion of Syphilis to Infectious Disease Clinical Trials, G7 Countries (%), 2016*
  • Syphilis Therapeutics, G7 Countries, Clinical Trials by Phase, 2016*
  • Syphilis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016*
  • Proportion of Syphilis to Infectious Disease Clinical Trials, E7 Countries (%), 2016*
  • Syphilis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016*
  • Syphilis Therapeutics, Global, Clinical Trials by Phase, 2016*
  • Syphilis Therapeutics, Global, Clinical Trials by Trial Status, 2016*
  • Syphilis Therapeutics Clinical Trials, Global, by End Point Status, 2016*
  • Syphilis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015
  • Syphilis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016*
  • Syphilis Therapeutics Clinical Trials, Global, Key Sponsors, 2016*
  • Syphilis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016*
  • Syphilis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016*

List of Figures

  • Syphilis Therapeutics, Global, Clinical Trials by Region (%), 2016*
  • Syphilis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016*
  • Syphilis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016*
  • Syphilis Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2016*
  • Syphilis Therapeutics Clinical Trials, Europe, Top Countries (%), 2016*
  • Syphilis Therapeutics Clinical Trials, North America, Top Countries (%), 2016*
  • Syphilis Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2016*
  • Proportion of Syphilis to Infectious Disease Clinical Trials, G7 Countries (%), 2016*
  • Syphilis Therapeutics, G7 Countries, Clinical Trials by Phase, 2016*
  • Syphilis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016*
  • Proportion of Syphilis to Infectious Disease Clinical Trials, E7 Countries (%), 2016*
  • Syphilis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016*
  • Syphilis Therapeutics, Global, Clinical Trials by Phase (%), 2016*
  • Syphilis Therapeutics, Global, Clinical Trials by Trial Status, 2016*
  • Syphilis Therapeutics Clinical Trials, Global, by End Point Status, 2016*
  • Syphilis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015
  • Syphilis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016*
  • Syphilis Therapeutics Clinical Trials, Global, Key Sponsors, 2016*
  • Syphilis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016*
  • Syphilis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016*
  • GlobalData Methodology
Back to Top